These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1052 related articles for article (PubMed ID: 30898857)

  • 1. Neutrophil plasticity in the tumor microenvironment.
    Giese MA; Hind LE; Huttenlocher A
    Blood; 2019 May; 133(20):2159-2167. PubMed ID: 30898857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment.
    Zhang Y; Guoqiang L; Sun M; Lu X
    Cancer Biol Med; 2020 Feb; 17(1):32-43. PubMed ID: 32296575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of neutrophils in cancer growth and progression.
    Galdiero MR; Varricchi G; Loffredo S; Mantovani A; Marone G
    J Leukoc Biol; 2018 Mar; 103(3):457-464. PubMed ID: 29345348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil Heterogeneity in Cancer: From Biology to Therapies.
    Lecot P; Sarabi M; Pereira Abrantes M; Mussard J; Koenderman L; Caux C; Bendriss-Vermare N; Michallet MC
    Front Immunol; 2019; 10():2155. PubMed ID: 31616408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil: A New Player in Metastatic Cancers.
    Wu M; Ma M; Tan Z; Zheng H; Liu X
    Front Immunol; 2020; 11():565165. PubMed ID: 33101283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD300ld on neutrophils is required for tumour-driven immune suppression.
    Wang C; Zheng X; Zhang J; Jiang X; Wang J; Li Y; Li X; Shen G; Peng J; Zheng P; Gu Y; Chen J; Lin M; Deng C; Gao H; Lu Z; Zhao Y; Luo M
    Nature; 2023 Sep; 621(7980):830-839. PubMed ID: 37674079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protumor and antitumor functions of neutrophil granulocytes.
    Brandau S; Dumitru CA; Lang S
    Semin Immunopathol; 2013 Mar; 35(2):163-76. PubMed ID: 23007469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated neutrophils: friend or foe?
    Fridlender ZG; Albelda SM
    Carcinogenesis; 2012 May; 33(5):949-55. PubMed ID: 22425643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-35 induces N2 phenotype of neutrophils to promote tumor growth.
    Zou JM; Qin J; Li YC; Wang Y; Li D; Shu Y; Luo C; Wang SS; Chi G; Guo F; Zhang GM; Feng ZH
    Oncotarget; 2017 May; 8(20):33501-33514. PubMed ID: 28432279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophils as active regulators of the immune system in the tumor microenvironment.
    Shaul ME; Fridlender ZG
    J Leukoc Biol; 2017 Aug; 102(2):343-349. PubMed ID: 28264904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Rosetta Stone for Breast Cancer: Prognostic Value and Dynamic Regulation of Neutrophil in Tumor Microenvironment.
    Zhang W; Shen Y; Huang H; Pan S; Jiang J; Chen W; Zhang T; Zhang C; Ni C
    Front Immunol; 2020; 11():1779. PubMed ID: 32849640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-Faced Roles of Tumor-Associated Neutrophils in Cancer Development and Progression.
    Mukaida N; Sasaki SI; Baba T
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neutrophils as tumor microenviroment member].
    Danilova AB; Baldueva IA
    Vopr Onkol; 2016; 62(1):35-44. PubMed ID: 30444330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-related circulating and tumor-associated neutrophils - subtypes, sources and function.
    Shaul ME; Fridlender ZG
    FEBS J; 2018 Dec; 285(23):4316-4342. PubMed ID: 29851227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment.
    Singel KL; Emmons TR; Khan ANH; Mayor PC; Shen S; Wong JT; Morrell K; Eng KH; Mark J; Bankert RB; Matsuzaki J; Koya RC; Blom AM; McLeish KR; Qu J; Ram S; Moysich KB; Abrams SI; Odunsi K; Zsiros E; Segal BH
    JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30730851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leveling Up the Controversial Role of Neutrophils in Cancer: When the Complexity Becomes Entangled.
    Sionov RV
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasticity of myeloid-derived suppressor cells in cancer.
    Tcyganov E; Mastio J; Chen E; Gabrilovich DI
    Curr Opin Immunol; 2018 Apr; 51():76-82. PubMed ID: 29547768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor promoting capacity of polymorphonuclear myeloid-derived suppressor cells and their neutralization.
    Groth C; Weber R; Lasser S; Özbay FG; Kurzay A; Petrova V; Altevogt P; Utikal J; Umansky V
    Int J Cancer; 2021 Nov; 149(9):1628-1638. PubMed ID: 34224592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphonuclear myeloid-derived suppressor cells link inflammation and damage response after trauma.
    Li X; Liu J; Xing Z; Tang J; Sun H; Zhang X; Lv S; Chen Z; Shi M; Chen M; Zuo S; Lyu X; He Y
    J Leukoc Biol; 2021 Dec; 110(6):1143-1161. PubMed ID: 34636072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer.
    Sagiv JY; Michaeli J; Assi S; Mishalian I; Kisos H; Levy L; Damti P; Lumbroso D; Polyansky L; Sionov RV; Ariel A; Hovav AH; Henke E; Fridlender ZG; Granot Z
    Cell Rep; 2015 Feb; 10(4):562-73. PubMed ID: 25620698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.